SELLAS Life Sciences (SLS) Non-Current Assets (2010 - 2026)

SELLAS Life Sciences (SLS) has 17 years of Non-Current Assets data on file, last reported at $3.0 million in Q1 2026.

• Quarterly Non-Current Assets rose 0.84% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 1.13% YoY) and the FY2025 annual result came in at $3.1 million, up 0.93% from the prior year.
• Non-Current Assets fell to $3.0 million in Q1 2026 per SLS's latest filing, from $3.1 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $3.6 million in Q1 2022 and bottomed at $2.5 million in Q3 2024.
• The 5-year median for Non-Current Assets is $3.0 million (2026), against an average of $3.0 million.
• The widest annual swing landed in 2022, when Non-Current Assets sank 62.17%; it then grew 1.9% in 2024.
• Tracing SLS's Non-Current Assets over 5 years: stood at $3.2 million in 2022, then declined by 4.39% to $3.0 million in 2023, then climbed by 1.9% to $3.1 million in 2024, then advanced by 0.93% to $3.1 million in 2025, then retreated by 4.02% to $3.0 million in 2026.
• Per Business Quant, the three latest SLS Non-Current Assets figures stand at $3.0 million (Q1 2026), $3.1 million (Q4 2025), and $2.5 million (Q3 2025).

Peer Comparison